Brief: Nanexa Demonstrates Quarterly Semaglutide Dosing Feasibility
19/03/2026 09:24
March 19 (Reuters) - Nanexa AB NANEXA.ST: NANEXA DEMONSTRATES FEASIBILITY OF QUARTERLY SEMAGLUTIDE DOSING WITH PHARMASHELL® NANEXA AB - DATA INDICATE SEMAGLUTIDE CAN BE ADMINISTERED ONCE QUARTERLY WITH CONTROLLED PLASMA CONCENTRATION Source text: ID:nMFN3s6DPp Further company coverage: NANEXA.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))